NIT
ANIK icon

NumerixS Investment Technologies’s Anika Therapeutics ANIK Stock Holding History

NumerixS Investment Technologies’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,160
Closed -$34K – 1057
2020
Q1 		$34K Buy
+1,160
New +$46.9K 0.02% 704
2017
Q4 		– Sell
-2,400
Closed -$139K – 1118
2017
Q3 		$139K Buy
2,400
+400
+20% +$20.9K 0.03% 635
2017
Q2 		$99K Buy
+2,000
New +$92.1K 0.01% 836

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NumerixS Investment Technologies's ANIK Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Anika Therapeutics (ANIK) in Q2 2020, closing a stake of 1,160 shares — an estimated $34K sold.

NumerixS Investment Technologies first reported a position in ANIK in Q2 2017 and held it in 3 quarters. The position peaked at $139K in Q3 2017. 158 funds tracked by Wall St. Rank hold ANIK as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Anika Therapeutics position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,160 Anika Therapeutics shares in Q2 2020, an estimated $34K.
  • NumerixS Investment Technologies first reported a position in Anika Therapeutics in Q2 2017 and held it in 3 quarters.
  • NumerixS Investment Technologies's Anika Therapeutics position peaked at $139K in Q3 2017.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.